Neuropharmacist faculty member’s project featured in MS Trust publication

11 July, 2019 | Posted in:

The MS Trust has just released its fifth issue of ‘MS in Practice’, a valuable resource outlining examples of positive practice and reviewing the practical application of new guidance for those with an interest in multiple sclerosis (MS). This particular issue features an article about the disease-modifying therapy (DMT) cost calculator, developed by neuropharmacist and […]

Continue Reading »

MS-STAT2 finally takes off

16 May, 2017 | Posted in: ,

by Professor Gavin Giovannoni Finally a phase 3 trial in progressive MS is being done outside of Big Pharma. Great news for people with progressive MS. We will now get an answer about whether or not simvastatin works in a larger study, its safety profile and more importantly its risk:benefit profile in people with more […]

Continue Reading »

#NeuroSpeak: education, education, education…

5 April, 2017 | Posted in:

by Prof Gavin Giovannoni What has Tony Blair got to do with multiple sclerosis? #MSBlog #NeuroSpeak Tony Blair is famously quoted as putting ‘Education, education, education, …’ at the centre of New Labour’s manifesto in 1997. However, it is the type, or quality, of education that makes a difference. I have learnt that information in […]

Continue Reading »